Clonixin

DB09218InvestigationalSmall molecule

Clonixin is an NSAID used to relieve pain associated with arthritis, migraines, and various soft tissue disorders. Clonixin is a non-steroidal anti-inflammatory drug.

Mechanism: The mechanism of clonixin does not appear to have been investigated on a molecular level. It is presumed to function similarly to other NSAIDs by inhibiting cycloxygenase enzymes 1 and 2 resulting in a reduction in prostaglandin production.
Curator reviewed
Primary indication: Indicated for use in the management of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.Curator reviewed · 2 structured indications
Formula / weight: C₁₃H₁₁ClN₂O₂ · 262.69 g/mol (avg)
Code names: CBA 93626 · SCH-10304

Resolves to

Compound

UNIIV7DXN0M42RCAS17737-65-4ChEMBLCHEMBL1332971ChEBI76200PubChem28718KEGGD03555

Clinical / RWD

RxNorm2601

Structure

InChIKeyCLOMYZFHNHFSIQ-UHFFFAOYSA-NSMILESCC1=C(NC2=C(C=CC=N2)C(O)=O)C=CC=C1Cl

Targets

P23219PTGS1P35354PTGS2

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,389Drug interactionsStructured to mechanism, not free text

2Structured indicationsCondition, population, route and combination as fields, not prose

7ContraindicationsEach with its own population and attribute set

8Marketed productsAcross 1 country and 5 labellers

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Clonixin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In